Literature DB >> 10948177

Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines.

J Vekemans1, C Truyens, F Torrico, M Solano, M C Torrico, P Rodriguez, C Alonso-Vega, Y Carlier.   

Abstract

The possibility of maternal in utero modulation of the innate and/or adaptive immune responses of uninfected newborns from Trypanosoma cruzi-infected mothers was investigated by studying the capacity of their whole blood cells to produce cytokines in response to T. cruzi lysate or lipopolysaccharide-plus-phytohemagglutinin (LPS-PHA) stimulation. Cells of such newborns occasionally released gamma interferon (IFN-gamma) and no interleukin-2 (IL-2) and IL-4 upon specific stimulation, while their mothers responded by the production of IFN-gamma, IL-2, and IL-4. Infection in mothers was also associated with a hyperactivation of maternal cells and also, strikingly, of cells of their uninfected neonates, since their release of proinflammatory (IL-1beta, IL-6, and tumor necrosis factor alpha [TNF-alpha]) as well as of anti-inflammatory (IL-10 and soluble TNF receptor) cytokines or factors was upregulated in the presence of LPS-PHA and/or parasite lysate. These results show that T. cruzi infection in mothers induces profound perturbations in the cytokine response of their uninfected neonates. Such maternal influence on neonatal innate immunity might contribute to limit the occurrence and severity of congenital infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948177      PMCID: PMC101811          DOI: 10.1128/IAI.68.9.5430-5434.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Ontogeny of T lymphocyte function in the neonate.

Authors:  C B Wilson; L Penix; W M Weaver; A Melvin; D B Lewis
Journal:  Am J Reprod Immunol       Date:  1992 Oct-Dec       Impact factor: 3.886

2.  Sensitization to Schistosoma mansoni antigen in uninfected children born to infected mothers.

Authors:  D Camus; Y Carlier; J C Bina; R Borojevic; A Prata; A Capron
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

3.  Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.

Authors:  M P Nunes; R M Andrade; M F Lopes; G A DosReis
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.

Authors:  F Plata; F Garcia-Pons; J Wietzerbin
Journal:  Ann Inst Pasteur Immunol       Date:  1987 May-Jun

5.  Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease.

Authors:  N R Sturm; W Degrave; C Morel; L Simpson
Journal:  Mol Biochem Parasitol       Date:  1989-03-15       Impact factor: 1.759

6.  Congenital Chagas' disease in Bolivia: epidemiological aspects and pathological findings.

Authors:  E Azogue; C La Fuente; C Darras
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

7.  Default development of cloned human naive CD4 T cells into interleukin-4- and interleukin-5- producing effector cells.

Authors:  L P Yang; D G Byun; C E Demeure; N Vezzio; G Delespesse
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

8.  Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.

Authors:  L Zhang; R L Tarleton
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

9.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; W A Buurman; A J Staal van den Brekel; M A Dentener; E F Wouters
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

10.  Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.

Authors:  F Plata; J Wietzerbin; F G Pons; E Falcoff; H Eisen
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

View more
  18 in total

1.  Trypanosoma cruzi activates cord blood myeloid dendritic cells independently of cell infection.

Authors:  Patricia Rodriguez; Yves Carlier; Carine Truyens
Journal:  Med Microbiol Immunol       Date:  2012-02-12       Impact factor: 3.402

2.  Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease.

Authors:  Laurent Brutus; Helen Castillo; Claudia Bernal; Nadin Alejandra Salas; Dominique Schneider; José-Antonio Santalla; Jean-Philippe Chippaux
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  The human fetal immune response to hepatitis C virus exposure in utero.

Authors:  Jennifer M Babik; Deborah Cohan; Alexander Monto; Dennis J Hartigan-O'Connor; Joseph M McCune
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis).

Authors:  Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

5.  Mother-to-Child Transmission of Trypanosoma cruzi.

Authors:  Hirut T Gebrekristos; Pierre Buekens
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

Review 6.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

Review 7.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

8.  Malaria modifies neonatal and early-life toll-like receptor cytokine responses.

Authors:  Komi Gbédandé; Stefania Varani; Samad Ibitokou; Parfait Houngbegnon; Sophie Borgella; Odilon Nouatin; Sem Ezinmegnon; Adicatou-Laï Adeothy; Gilles Cottrell; Achille Massougbodji; Kabirou Moutairou; Marita Troye-Blomberg; Philippe Deloron; Nadine Fievet; Adrian J F Luty
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

9.  Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines.

Authors:  Nicolas Dauby; Cristina Alonso-Vega; Eduardo Suarez; Amilcar Flores; Emmanuel Hermann; Marisol Córdova; Tatiana Tellez; Faustino Torrico; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2009-12-22

10.  Monocytes play an IL-12-dependent crucial role in driving cord blood NK cells to produce IFN-g in response to Trypanosoma cruzi.

Authors:  Aline Guilmot; Julie Bosse; Yves Carlier; Carine Truyens
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.